Company & Sponsor Intelligence
Duke University
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials1
Recruiting0
Completed1
Countries1
Therapeutic footprint
adhd
Indexed studies
NCT04294290Open Label Phase I hCT-MSC in Toddlers With Autism Spectrum Disorder
autism · United StatesPHASE1
autism · United StatesPHASE1
NCT03126682Effect of Bupropion on Seizure Threshold in Depressed Patients
depression · United StatesPHASE4
depression · United StatesPHASE4
NCT00037024Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer
depression · United StatesNA
depression · United StatesNA
NCT01123668Neuroimaging of Smokers With and Without Attention Deficit Hyperactivity Disorder (ADHD)
adhd · United StatesCOMPLETED
adhd · United StatesCOMPLETED
Intelligence layer updated: 2026-06-10 02:57:56.223123+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →